Ramelteon for Insomnia Treatment

Clinical Use and Efficacy

The American Academy of Sleep Medicine suggests ramelteon as an option for patients with sleep onset insomnia, particularly those who prefer not to use DEA-scheduled drugs or have a history of substance use disorders 1
Evidence suggests very weak efficacy for reducing sleep latency at the recommended 8 mg dosage, with mean decrease of 9.57 minutes, and no consistent evidence of improvement in other sleep parameters 2

Meta-analytic data shows a relatively low frequency of adverse effects overall, none significantly different from placebo 2
No evidence of rebound insomnia or withdrawal effects following discontinuation, even after six months of nightly use 2
No consistent evidence of next-day impairment in alertness, recall, or cognitive function 2
Unlike benzodiazepines and non-benzodiazepine hypnotics, ramelteon has not been associated with complex sleep behaviors or cognitive impairment 3

Ramelteon is particularly useful for patients with sleep onset insomnia rather than sleep maintenance problems 1, 2
Alcohol should be avoided when using ramelteon due to potential additive effects on sedation 4